Get started
Author

Hiroshi Kakeya

Observed names: H KAKEYA, H Kakeya, H. Kakeya, Hiroshi KAKEYA, Kakeya, H., Kakeya, Hiroshi
Observed institutions: Otsuka (Japan), National Institutes of Health, Osaka City University, Kurashiki Central Hospital, Nagoya University Hospital, Sasebo City General Hospital, National Institute of Allergy and Infectious Diseases, Ureshino Medical Center, Nagasaki University Hospital, Osaka City University Hospital, Toranomon Hospital, Nagasaki University, Osaka Metropolitan University, Saitama Cardiovascular and Respiratory Center, Japanese Red Cross Nagasaki Genbaku Isahaya Hospital, Isahaya General Hospital, The University of Osaka
ORCID: 0000-0002-6251-1696
Observed ORCID: 0000-0002-6251-1696
OpenAlex ID: A5044497202
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: A multicenter trial in Japan
2010 · Shigeru Kohno, Koichi Izumikawa, et al. · Journal of Infection · 133
PDF
Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia
1996 · K Mitsutake, T Miyazaki, et al. · Journal of Clinical Microbiology · 127
Correlation between Triazole Treatment History and Susceptibility in Clinically Isolated Aspergillus fumigatus
2012 · Masato Tashiro, Koichi Izumikawa, et al. · Antimicrobial Agents and Chemotherapy · 102
PDF
Random amplified polymorphic DNA analysis of clinically and environmentally isolated Cryptococcus neoformans in Nagasaki
1995 · Y Yamamoto, S Kohno, et al. · Journal of Clinical Microbiology · 92
Clinical features of pulmonary cryptococcosis in non-HIV patients in Japan
2014 · Shigeru Kohno, Hiroshi Kakeya, et al. · Journal of Infection and Chemotherapy · 89
Roles of Calcineurin and Crz1 in Antifungal Susceptibility and Virulence of Candida glabrata
2010 · Taiga Miyazaki, Shunsuke Yamauchi, et al. · Antimicrobial Agents and Chemotherapy · 88
Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan
2011 · Masato Tashiro, Koichi Izumikawa, et al. · Antimicrobial Agents and Chemotherapy · 86
Dissection of Ire1 Functions Reveals Stress Response Mechanisms Uniquely Evolved in Candida glabrata
2013 · Taiga Miyazaki, Hironobu Nakayama, et al. · PLoS Pathogens · 77
PDF
Diagnostic significance ofAspergillusspecies isolated from respiratory samples in an adult pneumology ward
2011 · Takayoshi Tashiro, Koichi Izumikawa, et al. · Medical Mycology · 76
PDF
Prevotella intermedia Induces Severe Bacteremic Pneumococcal Pneumonia in Mice with Upregulated Platelet-Activating Factor Receptor Expression
2013 · Kentaro Nagaoka, Katsunori Yanagihara, et al. · Infection and Immunity · 75
PDF
Genetic Analysis of Azole Resistance in the Darlington Strain of Candida albicans
2000 · Hiroshi Kakeya, Yoshitsugu Miyazaki, et al. · Antimicrobial Agents and Chemotherapy · 75
Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis
2012 · Koichi Izumikawa, Yoshihiro Yamamoto, et al. · Medical Mycology · 74
PDF
Role of the Slt2 mitogen-activated protein kinase pathway in cell wall integrity and virulence in Candida glabrata
2010 · Taiga Miyazaki, Tatsuo Inamine, et al. · FEMS Yeast Research · 69
PDF
Function of Candida glabrata ABC transporter gene, PDH1
2003 · Koichi Izumikawa, Hiroshi Kakeya, et al. · Yeast · 67
Skn7p Is Involved in Oxidative Stress Response and Virulence of Candida glabrata
2009 · Tomomi Saijo, Taiga Miyazaki, et al. · Mycopathologia · 59
Efficacy of Combination Therapy with Oseltamivir Phosphate and Azithromycin for Influenza: A Multicenter, Open-Label, Randomized Study
2014 · Hiroshi Kakeya, Masafumi Seki, et al. · PLoS ONE · 57
PDF
Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis
1999 · H KAKEYA, H UDONO, et al. · Clinical & Experimental Immunology · 56
PDF
A 77-kilodalton protein of Cryptococcus neoformans, a member of the heat shock protein 70 family, is a major antigen detected in the sera of mice with pulmonary cryptococcosis
1997 · H Kakeya, H Udono, et al. · Infection and Immunity · 54
PDF
Multilocus sequence typing ofCryptococcus neoformansin non-HIV associated cryptococcosis in Nagasaki, Japan
2012 · Tomo Mihara, Koichi Izumikawa, et al. · Medical Mycology · 53
In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen
2017 · Hiroshi Nishikawa, Yoshiko Fukuda, et al. · Journal of Antimicrobial Chemotherapy · 51
Detection of Cryptococcus neoformans gene in patients with pulmonary cryptococcosis
1996 · K Tanaka, T Miyazaki, et al. · Journal of Clinical Microbiology · 50
Fluconazole Treatment Is Effective against a Candida albicans erg3/erg3 Mutant In Vivo Despite In Vitro Resistance
2006 · Taiga Miyazaki, Yoshitsugu Miyazaki, et al. · Antimicrobial Agents and Chemotherapy · 49
Comparison between Wako-WB003 and Fungitec G tests for detection of (1→3)-β-D-glucan in systemic mycosis
1997 · Mohammad Ashraf Hossain, Takashige Miyazaki, et al. · Journal of Clinical Laboratory Analysis · 49
PDF
The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia
2019 · Takashi Ueda, Yoshio Takesue, et al. · PLoS ONE · 48
PDF
Synergistic Antifungal Effect of Lactoferrin with Azole Antifungals against Candida albicans and a Proposal for a New Treatment Method for Invasive Candidiasis
2011 · Tsutomu Kobayashi, Hiroshi Kakeya, et al. · Japanese Journal of Infectious Diseases · 48
PDF
Works count: 369
Citation count: 5,004
H-index: 37
I10-index: 150
Year
Topic
Type